Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shozo Yamada

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Endocrine Journal|April 12, 2021
GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegalyRie Nishio, Akira Takeshita, Toyoyoshi Uchida, et al.
Endocrine Journal|March 29, 2011
Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumorEmi Ishida, Masanobu Yamada, Kazuhiko Horiguchi, et al.
Pituitary|April 22, 2022
Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activityHiroki Shichi, Hidenori Fukuoka, Maki Kanzawa, et al.
The American Journal of Surgical Pathology|July 9, 2026
Clinicopathologic Analysis of 43 Surgically Resected Lactotroph Pituitary Neuroendocrine Tumors Stratified by Surgical Indication: A Pathologic Reappraisal of Apparent Male AggressivenessNoriaki Tanabe, Naoko Inoshita, Eri Kasuga, et al.
Iscience|November 1, 2024
Deciphering craniopharyngioma subtypes: Single-cell analysis of tumor microenvironment and immune networksTatsuma Matsuda, Takashi Kono, Yuki Taki, et al.
CEN Case Reports|October 6, 2022
Marked reduction of proteinuria after removal of a growth hormone-producing pituitary adenoma in a patient with focal segmental glomerulosclerosis: a case report and literature reviewShizuka Ishigaki, Yuji Oe, Kei Omata, et al.
Journal of Neurosurgery|April 24, 2026
Molecular markers of Rathke's cleft cysts and their clinical correlates: insights from experimental and human analysesYuriko Sasaki, Hironori Bando, Maki Kanzawa, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2017
Prednisolone-responsive Postpartum IgG4-related HypophysitisHisashi Koide, Akina Shiga, Eri Komai, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 2013
DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary TumorsToshio Hirohata, Kenichiro Asano, Yoshikazu Ogawa, et al.
Communications Biology|November 26, 2022
Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumorsAzusa Yamato, Hidekazu Nagano, Yue Gao, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Endocrine Journal|April 12, 2021
GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegalyRie Nishio, Akira Takeshita, Toyoyoshi Uchida, et al.
Endocrine Journal|March 29, 2011
Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumorEmi Ishida, Masanobu Yamada, Kazuhiko Horiguchi, et al.
Pituitary|April 22, 2022
Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activityHiroki Shichi, Hidenori Fukuoka, Maki Kanzawa, et al.
The American Journal of Surgical Pathology|July 9, 2026
Clinicopathologic Analysis of 43 Surgically Resected Lactotroph Pituitary Neuroendocrine Tumors Stratified by Surgical Indication: A Pathologic Reappraisal of Apparent Male AggressivenessNoriaki Tanabe, Naoko Inoshita, Eri Kasuga, et al.
Iscience|November 1, 2024
Deciphering craniopharyngioma subtypes: Single-cell analysis of tumor microenvironment and immune networksTatsuma Matsuda, Takashi Kono, Yuki Taki, et al.
CEN Case Reports|October 6, 2022
Marked reduction of proteinuria after removal of a growth hormone-producing pituitary adenoma in a patient with focal segmental glomerulosclerosis: a case report and literature reviewShizuka Ishigaki, Yuji Oe, Kei Omata, et al.
Journal of Neurosurgery|April 24, 2026
Molecular markers of Rathke's cleft cysts and their clinical correlates: insights from experimental and human analysesYuriko Sasaki, Hironori Bando, Maki Kanzawa, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2017
Prednisolone-responsive Postpartum IgG4-related HypophysitisHisashi Koide, Akina Shiga, Eri Komai, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 2013
DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary TumorsToshio Hirohata, Kenichiro Asano, Yoshikazu Ogawa, et al.
Communications Biology|November 26, 2022
Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumorsAzusa Yamato, Hidekazu Nagano, Yue Gao, et al.
Pageof 19